Corporate Shake-Ups, Drug Price Cuts, and Labor Tensions Dominate Market Headlines
Key Takeaways Warner Bros. Discovery (WBD) is officially on the market, with a public announcement of its sale plans anticipated […]
BAC
Global Economic Landscape: SNB’s Policy, Telecom Italia’s Strong Q3, BofA’s Expansion, and Trump’s Economic Focus
Key Takeaways Telecom Italia (TIT) reported robust 9-month 2025 financial results, with group revenue reaching EUR10 billion and EBITDA After
Bank of America Sets Ambitious 3-5 Year Targets Amidst Mixed Economic Signals; ECB Remains Cautious
Key Takeaways Bank of America (BAC) has outlined robust financial targets for the next 3-5 years, including a 16-18% Return
Global Markets Navigate Fed Hawkishness, Geopolitical Tensions Amidst Busy Earnings Week
Key Takeaways Federal Reserve officials signal a hawkish stance, with Logan finding further rate cuts difficult and Schmid dissenting against
Wall Street Surges on Tech Optimism, Congressional Stock Ban Heats Up, and Fed Signals Balance Sheet Shift
Key Takeaways Wall Street saw a robust rebound on Monday, October 20, with major indexes climbing as investors "bought the
Market Jitters Persist: Regional Bank Woes Drag Futures, Gold Hits Record High
U.S. stock futures displayed a mixed to sharply lower trend in premarket trading on Friday, October 17, 2025, as renewed
Market Shifts: Analyst Adjustments, Iron Ore Slump, and Geopolitical Tensions
Key Takeaways JP Morgan has reportedly lowered its price target for Sunoco LP (SUN) to $65 from $67. Barclays has
Wall Street Navigates Volatility Amid Strong Bank Earnings and Fed Rate Cut Hopes
U.S. stock markets displayed a mixed but largely positive performance in afternoon trading on Wednesday, October 15, 2025, as investors
[Earnings]Upcoming Earnings: Tech Giants and Financials Dominate Next Week’s Calendar
Market movers include Taiwan Semiconductor Manufacturing Company Ltd. pre-market Thursday, followed by Netflix Inc. after close Next Tuesday and Tesla
Eli Lilly’s Oral GLP-1 Orforglipron Shines in Phase 3, Bank of America Delivers Strong Q3 Earnings
Key Takeaways Eli Lilly's (LLY) oral GLP-1 drug, Orforglipron, demonstrated superior glycemic control in two successful Phase 3 trials, positioning